Cancer and Cardiovascular Disease: The Complex Labyrinth

Journal of Oncology

Volumn 2015, Issue , 2015, Pages

  Dent, Susan ^a   Liu, Peter ^b   Brezden Masley, Christine ^c   Lenihan, Daniel ^d  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84939864082     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2015/516450     Document Type: Editorial

References (10)

1. J. A. Driver, L. Djoussé, G. Logroscino, J. M. Gaziano, and T. Kurth, "Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study," British Medical Journal, vol. 337, Article IDa2467, 2008.
2. G. T. Armstrong, K. C. Oeffinger, Y. Chen et al., "Modifiable risk factors and major cardiac events among adult survivors of childhood cancer," Journal of Clinical Oncology, vol. 31, no. 29, pp. 3673-3680, 2013.
3. B. R. J. Healey Bird and S. M. Swain, "Cardiac toxicity in breast cancer survivors: review of potential cardiac problems," Clinical Cancer Research, vol. 14, no. 1, pp. 14-24, 2008.
4. A. Hossain, A. Chen, P. Ivy et al., "The importance of clinical grading of heart failure and other cardiac toxicities during chemotherapy: updating the common terminology criteria for clinical trial reporting," Heart Failure Clinics, vol. 7, no. 3, pp. 373-384, 2011.
5. K. C. Oeffinger, A. C.Mertens, C. A. Sklar et al., "Chronichealth conditions in adult survivors of childhood cancer," The New England Journal of Medicine, vol. 355, no. 15, pp. 1572-1582, 2006.
6. E. H. Romond, E. A. Perez, J. Byrant et al., "Trastuzumab plus adjuvant chemotherapy for operable HER-positive breast cancer," The New England Journal of Medicine, vol. 353, pp. 1673-1684, 2005.
7. M. J. Piccart-Gebhart, M. Procter, B. Leyland-Jones et al., "Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer," The New England Journal of Medicine, vol. 353, no. 16, pp. 1659-1672, 2005.
8. A. Seidman, C. Hudis, M. Kathryn Pierri et al., "Cardiac dysfunction in the trastuzumab clinical trials experience," Journal of Clinical Oncology, vol. 20, no. 5, pp. 1215-1221, 2002.
9. D. J. Lenihan, D. Cardinale, andC. M. Cipolla, "The compelling need for a cardiology and oncology partnership and the birth of the international cardioncology society," Progress in Cardiovascular Diseases, vol. 53, no. 2, pp. 88-93, 2010.
10. M. S. Ewer and D. J. Lenihan, "Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?" Journal of Clinical Oncology, vol. 26, no. 8, pp. 1201-1203, 2008.